← Eichor
Study identifier: NCT06249750 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer

Condition: Metastatic Castration-resistant Prostate Cancer (CRPC)  ·  Sponsor: Pengyuan Liu

PhasePhase 2
Planned participants60
Who can joinMale, 18 Years to 90 Years
Healthy volunteersNo

About this study

In this study, we propose to use the combination of ET-SPACE NIR irradiation whole-body thermal stimulation, ICI (Tislelizumab), and RTK inhibitor (Anlotinib) in the multimodal treatment of CRPC.

This description comes directly from the study's public registry record.

Talk to the study team

Pengyuan Liu  ·  18368846455  ·  oncologyliupengyuan@outlook.com

Always discuss trial participation with your own doctor first.

Locations (1)

Zhejiang HospitalHangzhou, Zhejiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06249750